Biochemistry, Genetics and Molecular Biology
DNA Methylation
100%
Methylation
74%
Epigenetics
48%
Genetics
29%
Gene Expression
22%
Genomics
21%
Methylome
20%
CRISPR/Cas9
19%
Bisulfite Sequencing
19%
Open Reading Frame
18%
CpG Island
17%
Long Non-Coding RNA
14%
Epigenomics
12%
Epigenetics
12%
Transcription
12%
Carcinogenesis
12%
Single-Nucleotide Polymorphism
11%
Enhancer Region
11%
Tamsulosin
10%
Genetic Marker
9%
Cas9 Protein
9%
Molecular Network
9%
Dynamics
9%
Homologous Recombination
9%
Messenger RNA
9%
GATA3
9%
CRISPR Interference
9%
Radiosensitivity
9%
Cholesterol Synthesis
9%
Drug Response
9%
Tumor Marker
9%
Pseudogene
9%
KLF5
9%
SARS Coronavirus
9%
MicroRNA
9%
Transcription Factor
9%
Long Noncoding RNA
8%
Histone Modification
7%
Cohesin
6%
Cancer Cell
6%
CRISPR
6%
Gene Expression Omnibus Database
6%
Gene Control
5%
Regulatory Network
5%
Genetic Variation
5%
Interactome
5%
Keyphrases
DNA Methylation (DNAm)
26%
Methylation
25%
Epigenetic Regulation
18%
Methylation Status
13%
Breast Cancer
12%
Cancer Tissue
11%
Cell Population
10%
Hypomethylation
9%
Methylome
9%
DNA Methylation Signature
9%
Ribosomal DNA
9%
Distinct Roles
9%
Bisulfite Sequencing
9%
Cancer Marker
9%
Dynamic Identification
9%
Molecular Markers
9%
Breast Cancer Heterogeneity
9%
Methylation Changes
9%
Integrative Analysis
9%
Human Breast Cancer
9%
Copy number
9%
Circulating microRNA
9%
Deconvolution
9%
DARS-AS1
9%
Lens Transparency
9%
RNA Transcription
9%
Maximum Likelihood Model
9%
CIMP
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Cell Identity
9%
Dynamic DNA Methylation
9%
Ensemble Predictors
9%
Information Repository
9%
Type-specific
9%
Age-associated
9%
Survival Disparities
9%
Molecular Network
9%
Identity Genes
9%
Single nucleotide Polymorphism
9%
Systematic Identification
9%
Tumor
9%
Epigenetic Modification
7%
Aging
7%
Cancer-related
7%
MicroRNA
7%
Tumor Heterogeneity
7%
CpG Island Methylator Phenotype
7%
Gene Expression
6%
DAZAP2
6%
Gene Regulation
6%
